The US FDA has broadened its investigation into AstraZeneca COVID-19 vaccine candidate
The US Food and Drug Administration iw widening the enquiry, seeking more data from clinical trials
- FDA seeking raw safety data from clinical trials of similar vaccines developed by same scientists
- The FDA does not necessarily indicate a safety problem associated with any of those vaccines
The market has been acting constructively on positive coronavirus vaccine stories. This is not a positive (in the short term at least) so should impact the opposite on risk.